Abstract
Simple and reproducible formulation strategies are needed to improve the bio-availability of curcumin. In this study, curcumin was successfully complexed with two boron-based compounds: 2-aminoethyl diphenyl borate (DPBA) and bortezomib (BTZ; Velcade®). In reverse-phase high-performance liquid chromatography, DPBA/curcumin complexes (DPBA/cur) showed delayed elution times compared to those of free curcumin. The UV–visible absorbance peak of DPBA/cur and BTZ and curcumin complexes (BTZ/cur) appeared redshifted. DPBA complexation has a negligible effect on the antioxidant and antiproliferation properties of curcumin for two types of cancer cells: MCF-7 and A549. Thus, curcumin complexation with boron-based compounds could be a method to enhance in vivo stability without loss of bioactivity (i.e., antioxidant and antiproliferation effects).
Similar content being viewed by others
References
Kuttan R, Bhanumathy P, Nirmala K, George MC (1985) Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29(2):197–202
Bar-Sela G, Epelbaum R, Schaffer M (2010) Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem 17(3):190–197
Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE (2014) Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials 35(10):3365–3383
Sun DM, Zhuang XY, Grizzle W, Miller D, Zhang HG (2011) A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Cancer Res 71
Hasan M, Belhaj N, Benachour H, Barberi-Heyob M, Kahn CJF, Jabbari E, Linder M, Arab-Tehrany E (2014) Liposome encapsulation of curcumin: physico-chemical characterizations and effects on MCF7 cancer cell proliferation. Int J Pharm 461(1–2):519–528
Yallapu MM, Jaggi M, Chauhan SC (2012) Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 17(1–2):71–80
Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, Tharakan ST, Misra K, Priyadarsini IK, Rajasekharan KN, Aggarwal BB (2008) Biological activities of curcumin and its analogues (Congeners) made by man and mother nature. Biochem Pharmacol 76(11):1590–1611
Liu YM, Lee K (2009) Modifications of the curcumin method enabling precise and accurate measurement of seawater boron concentration. Mar Chem 115(1–2):110–117
Sah RN, Brown PH (1997) Boron determination—a review of analytical methods. Microchem J 56(3):285–304
Wimmer MA, Goldbach HE (1999) A miniaturized curcumin method for the determination of boron in solutions and biological samples. J Plant Nutr Soil Sc 162(1):15–18
Mair JW Jr, Day HG (1972) Curcumin method for spectrophotometric determination of boron extracted from radiofrequency ashed animal tissues using 2-ethyl-1,3-hexanediol. Anal Chem 44(12):2015–2017
Baker SJ, Ding CZ, Akama T, Zhang YK, Hernandez V, Xia Y (2009) Therapeutic potential of boron-containing compounds. Future Med Chem 1(7):1275–1288
Hunter P (2009) Not boring at all Boron is the new carbon in the quest for novel drug candidates. EMBO Rep 10(2):125
Kang YY, Jung H, Yu G, Chong Y, Mok H (2016) Complexation of curcumin with 2-aminoethyl diphenyl borate and implications for spatiotemporal fluorescence monitoring. Int J Pharm 515(1–2):669–676
Medel S, Syrova Z, Kovacik L, Hrdy J, Hornacek M, Jager E, Hruby M, Lund R, Cmarko D, Stepanek P, Raska I, Nyström B (2017) Curcumin-bortezomib loaded polymeric nanoparticles for synergistic cancer therapy. Eur Polym J 93:116–131
Aghajanian C, Soignet S, Dizon DS, Pien CS, Adams J, Elliott PJ, Sabbatini P, Miller V, Hensley ML, Pezzulli S, Canales C, Daud A, Spriggs DR (2002) A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies. Clin Cancer Res 8(8):2505–2511
Kouroukis TC, Baldassarre FG, Haynes AE, Imrie K, Reece DE, Cheung MC (2014) Bortezomib in multiple myeloma: systematic review and clinical considerations. Curr Oncol 4:e573–e603
Park J, Ayyappan V, Bae EK, Lee C, Kim BS, Kim BK, Lee YY, Ahn KS, Yoon SS (2008) Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells. Mol Oncol 2(4):317–326
Mujtaba T, Kanwar J, Wan SB, Chan TH, Dou QP (2012) Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs. Int J Mol Med 29(1):102–106
Alberti D, Protti N, Franck M, Stefania R, Bortolussi S, Altieri S, Deagostino A, Aime S, Geninatti Crich S (2017) Theranostic nanoparticles loaded with imaging probes and rubrocurcumin for combined cancer therapy by folate receptor targeting. Chem Med Chem 12(7):502–509
Donaldson EM (1981) Spectrophotometric determination of boron in iron and steel with curcumin after separation by 2-ethyl-1,3-hexanediol-chloroform extraction. Talanta 28(11):825–831
Brand-Williams W, Cuvelier ME, Berset C (1995) Use of a free-radical method to evaluate antioxidant activity. Food Sci Technol-Leb 28(1):25–30
Chen A, Xu J, Johnson AC (2006) Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25(2):278–287
Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G (2002) Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512(1–3):334–340
Qiu X, Du YH, Lou B, Zuo YL, Shao WY, Huo YP, Huang JN, Yu YJ, Zhou BH, Du J, Fu H, Bu XZ (2010) Synthesis and identification of new 4-Arylidene curcumin analogues as potential anticancer agents targeting nuclear factor-kappa b signaling pathway. J Med Chem 53(23):8260–8273
Agrawal DK, Mishra PK (2010) Curcumin and its analogues: potential anticancer agents. Med Res Rev 30(5):818–860
Simon A, Allais DP, Duroux JL, Basly JP, Durand-Fontanier S, Delage C (1998) Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Lett 129(1):111–116
Radhakrishna Pillai G, Srivastava AS, Hassanein TI, Chauhan DP, Carrier E (2004) Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 208(2):163–170
Acknowledgments
This work was supported by the Agri-Bio Industry Technology Development Program (316028-3), Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET), Republic of Korea.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, J.Y., Kang, Y.Y., Kim, E.J. et al. Effects of curcumin-/boron-based compound complexation on antioxidant and antiproliferation activity. Appl Biol Chem 61, 403–408 (2018). https://doi.org/10.1007/s13765-018-0374-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13765-018-0374-4